BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wilcox RA. Cutaneous T-cell lymphoma: 2016 update on diagnosis, risk-stratification, and management. Am J Hematol 2016;91:151-65. [PMID: 26607183 DOI: 10.1002/ajh.24233] [Cited by in Crossref: 72] [Cited by in F6Publishing: 60] [Article Influence: 10.3] [Reference Citation Analysis]
Number Citing Articles
1 Gu X, Wang Y, Zhang C, Liu Y. GFI-1 overexpression promotes cell proliferation and apoptosis resistance in mycosis fungoides by repressing Bax and P21. Oncol Lett 2021;22:521. [PMID: 34025788 DOI: 10.3892/ol.2021.12782] [Reference Citation Analysis]
2 Fredholm S, Willerslev-Olsen A, Met Ö, Kubat L, Gluud M, Mathiasen SL, Friese C, Blümel E, Petersen DL, Hu T, Nastasi C, Lindahl LM, Buus TB, Krejsgaard T, Wasik MA, Kopp KL, Koralov SB, Persson JL, Bonefeld CM, Geisler C, Woetmann A, Iversen L, Becker JC, Ødum N. SATB1 in Malignant T Cells. J Invest Dermatol 2018;138:1805-15. [PMID: 29751003 DOI: 10.1016/j.jid.2018.03.1526] [Cited by in Crossref: 21] [Cited by in F6Publishing: 24] [Article Influence: 5.3] [Reference Citation Analysis]
3 Ahmed N, Feldman AL. Targeting epigenetic regulators in the treatment of T-cell lymphoma. Expert Rev Hematol 2020;13:127-39. [PMID: 31903826 DOI: 10.1080/17474086.2020.1711732] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
4 Ghiciuc CM, Strat AL, Ochiuz L, Lupusoru CE, Ignat M, Vasile A, Grigorovici A, Stoleriu I, Solcan C. Inhibition of bcl-2 and cox-2 Protein Expression after Local Application of a New Carmustine-Loaded Clinoptilolite-Based Delivery System in a Chemically Induced Skin Cancer Model in Mice. Molecules 2017;22:E2014. [PMID: 29156646 DOI: 10.3390/molecules22112014] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
5 Li H, Wang C, Ma P, Zhang M, Yang H, Yuan S, Wei J, Tao L, Qian K, Xu M, Li L. The retinoid derivant ECPIRM selectively exhibited anti-proliferation effects in cutaneous T-Cell lymphoma via ITK-mediated signaling pathway. J Dermatol Sci 2020;97:208-15. [PMID: 32165081 DOI: 10.1016/j.jdermsci.2020.01.013] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
6 Bailiff OA, Mowad CM. Mimics of Dermatitis. Immunol Allergy Clin North Am 2021;41:493-515. [PMID: 34225903 DOI: 10.1016/j.iac.2021.04.009] [Reference Citation Analysis]
7 Martinez XU, Di Raimondo C, Abdulla FR, Zain J, Rosen ST, Querfeld C. Leukaemic variants of cutaneous T-cell lymphoma: Erythrodermic mycosis fungoides and Sézary syndrome. Best Pract Res Clin Haematol 2019;32:239-52. [PMID: 31585624 DOI: 10.1016/j.beha.2019.06.004] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
8 Silva-Hirschberg C, Hartman H, Stack S, Swenson S, Minea RO, Davitz MA, Chen TC, Schönthal AH. Cytotoxic impact of a perillyl alcohol-temozolomide conjugate, NEO212, on cutaneous T-cell lymphoma in vitro. Ther Adv Med Oncol 2019;11:1758835919891567. [PMID: 31839810 DOI: 10.1177/1758835919891567] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
9 Dimitriou F, Schanz U, Nair G, Kimeswenger S, Brüggen MC, Hoetzenecker W, French LE, Dummer R, Cozzio A, Guenova E. Long-Term Disease Control After Allogeneic Hematopoietic Stem Cell Transplantation in Primary Cutaneous T-Cell Lymphoma; Results From a Single Institution Analysis. Front Med (Lausanne) 2020;7:290. [PMID: 32714935 DOI: 10.3389/fmed.2020.00290] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
10 Stranzenbach R, Theurich S, Schlaak M. [Role of stem cell transplantation in treatment of primary cutaneous T‑cell lymphoma]. Hautarzt 2017;68:716-20. [PMID: 28785925 DOI: 10.1007/s00105-017-4023-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
11 Padmanabhan A, Connelly-Smith L, Aqui N, Balogun RA, Klingel R, Meyer E, Pham HP, Schneiderman J, Witt V, Wu Y, Zantek ND, Dunbar NM, Schwartz GEJ. Guidelines on the Use of Therapeutic Apheresis in Clinical Practice - Evidence-Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue. J Clin Apher. 2019;34:171-354. [PMID: 31180581 DOI: 10.1002/jca.21705] [Cited by in Crossref: 314] [Cited by in F6Publishing: 277] [Article Influence: 104.7] [Reference Citation Analysis]
12 Podkonjak T, Cranmer H, Scarisbrick J, McCarthy G, Lilley C, Cheng LI. Cost-effectiveness of brentuximab vedotin for the treatment of cutaneous T-cell lymphoma. J Comp Eff Res 2021. [PMID: 34879742 DOI: 10.2217/cer-2021-0201] [Reference Citation Analysis]
13 Akone SH, Ntie-Kang F, Stuhldreier F, Ewonkem MB, Noah AM, Mouelle SEM, Müller R. Natural Products Impacting DNA Methyltransferases and Histone Deacetylases. Front Pharmacol 2020;11:992. [PMID: 32903500 DOI: 10.3389/fphar.2020.00992] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
14 Buus TB, Willerslev-Olsen A, Fredholm S, Blümel E, Nastasi C, Gluud M, Hu T, Lindahl LM, Iversen L, Fogh H, Gniadecki R, Litvinov IV, Persson JL, Bonefeld CM, Geisler C, Christensen JP, Krejsgaard T, Litman T, Woetmann A, Ødum N. Single-cell heterogeneity in Sézary syndrome. Blood Adv 2018;2:2115-26. [PMID: 30139925 DOI: 10.1182/bloodadvances.2018022608] [Cited by in Crossref: 36] [Cited by in F6Publishing: 30] [Article Influence: 12.0] [Reference Citation Analysis]
15 Wen P, Xie Y, Wang L. The Role of microRNA in Pathogenesis, Diagnosis, Different Variants, Treatment and Prognosis of Mycosis Fungoides. Front Oncol 2021;11:752817. [PMID: 34966672 DOI: 10.3389/fonc.2021.752817] [Reference Citation Analysis]
16 Talaat IM, Abdelmaksoud RE, Guimei M, Agamia NF, Nugud A, El-Serafi AT. Potential role for microRNA-16 (miR-16) and microRNA-93 (miR-93) in diagnosis and prediction of disease progression in mycosis fungoides in Egyptian patients. PLoS One 2019;14:e0224305. [PMID: 31648231 DOI: 10.1371/journal.pone.0224305] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
17 Wohlmuth-Wieser I, Ramjist JM, Shear N, Alhusayen R. Morphologic Features of Cutaneous T-Cell Lymphomas Using Dermoscopy and High Frequency Ultrasound. J Clin Med 2020;10:E17. [PMID: 33374774 DOI: 10.3390/jcm10010017] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Alaibac M. Monoclonal antibodies against cutaneous T-cell lymphomas. Expert Opinion on Biological Therapy 2017;17:1503-10. [DOI: 10.1080/14712598.2017.1369951] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
19 Zhang XH, Nam S, Wu J, Chen CH, Liu X, Li H, McKeithan T, Gong Q, Chan WC, Yin HH, Yuan YC, Pillai R, Querfeld C, Horne D, Chen Y, Rosen ST. Multi-Kinase Inhibitor with Anti-p38γ Activity in Cutaneous T-Cell Lymphoma. J Invest Dermatol 2018;138:2377-87. [PMID: 29758280 DOI: 10.1016/j.jid.2018.04.030] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
20 Moyal L, Goldfeiz N, Gorovitz B, Rephaeli A, Tal E, Tarasenko N, Nudelman A, Ziv Y, Hodak E. AN-7, a butyric acid prodrug, sensitizes cutaneous T-cell lymphoma cell lines to doxorubicin via inhibition of DNA double strand breaks repair. Invest New Drugs 2018;36:1-9. [PMID: 28884410 DOI: 10.1007/s10637-017-0500-x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
21 Marks JA, Switchenko JM, Martini DJ, Tarabadkar ES, Khan MK, Lechowicz MJ, Allen PB. T-Cell Receptor Gene Rearrangement Clonality, Flow Cytometry Status, and Associated Outcomes in Early-Stage Cutaneous T-Cell Lymphoma. JAMA Dermatol 2021;157:954-62. [PMID: 34190977 DOI: 10.1001/jamadermatol.2021.2191] [Reference Citation Analysis]
22 Bassuner J, Miranda RN, Emge DA, DiCicco BA, Lewis DJ, Duvic M. Mycosis Fungoides of the Oral Cavity: Fungating Tumor Successfully Treated with Electron Beam Radiation and Maintenance Bexarotene. Case Rep Dermatol Med 2016;2016:5857935. [PMID: 28074163 DOI: 10.1155/2016/5857935] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
23 Scarfò I, Frigault MJ, Maus MV. CAR-Based Approaches to Cutaneous T-Cell Lymphoma. Front Oncol 2019;9:259. [PMID: 31058076 DOI: 10.3389/fonc.2019.00259] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
24 Bahalı AG, Su O, Cengiz FP, Emiroğlu N, Ozkaya DB, Onsun N. Prognostic factors of patients with mycosis fungoides. Postepy Dermatol Alergol 2020;37:796-9. [PMID: 33240023 DOI: 10.5114/ada.2020.100491] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
25 Pileri A, Agostinelli C, Sessa M, Quaglino P, Santucci M, Tomasini C, Grandi V, Fava P, Astrua C, Righi S, Patrizi A, Pileri SA, Pimpinelli N. Langerhans, plasmacytoid dendritic and myeloid-derived suppressor cell levels in mycosis fungoides vary according to the stage of the disease. Virchows Arch 2017;470:575-82. [DOI: 10.1007/s00428-017-2107-1] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.6] [Reference Citation Analysis]
26 Dault JB, Slade AN, Zhao S, Song S. Comparison of low-dose and standard-dose total skin electron beam therapy in mycosis fungoides. Leuk Lymphoma 2019;60:2334-6. [PMID: 30760058 DOI: 10.1080/10428194.2019.1574008] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
27 Gao SJ, Decker RH. Contemporary Topics in Radiation Medicine: Skin Cancer. Hematol Oncol Clin North Am 2020;34:189-203. [PMID: 31739944 DOI: 10.1016/j.hoc.2019.09.008] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
28 Alnasser MA, AlKhawajah NM, AlQadri NG, Shadid AM, Alsaif FM. Erythrodermic CD4/CD8 Double-Negative Mycosis Fungoides: A Case Report. Case Rep Oncol 2021;14:256-61. [PMID: 33776713 DOI: 10.1159/000512822] [Reference Citation Analysis]
29 Rivera-Munoz P, Laurent AP, Siret A, Lopez CK, Ignacimouttou C, Cornejo MG, Bawa O, Rameau P, Bernard OA, Dessen P, Gilliland GD, Mercher T, Malinge S. Partial trisomy 21 contributes to T-cell malignancies induced by JAK3-activating mutations in murine models. Blood Adv 2018;2:1616-27. [PMID: 29986854 DOI: 10.1182/bloodadvances.2018016089] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
30 D'Agostino P, Kent A, Sharp E, Schmidt F, Turini M. Mycosis fungoides-type cutaneous T-cell lymphoma (MF-CTCL) epidemiology and treatment pathway in Spain: new insights for an accurate description. Drugs Context 2020;9:2020-4-8. [PMID: 32821261 DOI: 10.7573/dic.2020-4-8] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
31 Smith EH, Chan MP. Inflammatory Dermatopathology for General Surgical Pathologists. Clin Lab Med 2017;37:673-96. [PMID: 28802506 DOI: 10.1016/j.cll.2017.05.008] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
32 Argnani L, Broccoli A, Zinzani PL. Cutaneous T-cell lymphomas: Focusing on novel agents in relapsed and refractory disease. Cancer Treat Rev 2017;61:61-9. [PMID: 29102679 DOI: 10.1016/j.ctrv.2017.10.007] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 3.6] [Reference Citation Analysis]
33 Radonjic-Hoesli S, Brüggen MC, Feldmeyer L, Simon HU, Simon D. Eosinophils in skin diseases. Semin Immunopathol 2021;43:393-409. [PMID: 34097126 DOI: 10.1007/s00281-021-00868-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
34 Carter CA, Zeman K, Day RM, Richard P, Oronsky A, Oronsky N, Lybeck M, Scicinski J, Oronsky B. Addressing the elephant in the room, therapeutic resistance in non-small cell lung cancer, with epigenetic therapies. Oncotarget 2016;7:40781-91. [PMID: 27007055 DOI: 10.18632/oncotarget.8205] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
35 Bagherani N, Smoller BR. An overview of cutaneous T cell lymphomas. F1000Res 2016;5:F1000 Faculty Rev-1882. [PMID: 27540476 DOI: 10.12688/f1000research.8829.1] [Cited by in Crossref: 35] [Cited by in F6Publishing: 26] [Article Influence: 5.8] [Reference Citation Analysis]
36 Harper-kirksey K. Erythroderma. In: Rose E, editor. Life-Threatening Rashes. Cham: Springer International Publishing; 2018. pp. 265-77. [DOI: 10.1007/978-3-319-75623-3_19] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
37 Olszewska B, Gleń J, Zabłotna M, Nowicki RJ, Sokołowska-Wojdyło M. The polymorphisms of IL-6/STAT3 signaling pathway may contribute to cutaneous T-cell lymphomas susceptibility. Arch Dermatol Res 2021;313:25-31. [PMID: 32270320 DOI: 10.1007/s00403-020-02062-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
38 Hosoi H, Hatanaka K, Murata S, Mushino T, Kuriyama K, Nishikawa A, Hanaoka N, Tamura S, Nakakuma H, Sonoki T. Long-term complete remission of early hematological relapse after discontinuation of immunosuppressants following allogeneic transplantation for Sezary syndrome. Hematol Rep 2018;10:7497. [PMID: 30283619 DOI: 10.4081/hr.2018.7497] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
39 Krejsgaard T, Lindahl LM, Mongan NP, Wasik MA, Litvinov IV, Iversen L, Langhoff E, Woetmann A, Odum N. Malignant inflammation in cutaneous T-cell lymphoma-a hostile takeover. Semin Immunopathol 2017;39:269-82. [PMID: 27717961 DOI: 10.1007/s00281-016-0594-9] [Cited by in Crossref: 57] [Cited by in F6Publishing: 58] [Article Influence: 9.5] [Reference Citation Analysis]
40 Erraji H, Hali F, Baline K, Marnissi F, Chiheb S. [Epidemiological and clinical profile and outcome in 166 mycosis fungoides patients in Casablanca]. Ann Dermatol Venereol 2019;146:825-8. [PMID: 31519349 DOI: 10.1016/j.annder.2019.08.006] [Reference Citation Analysis]
41 Cheng JW, Hon KL, Leung AKC. A polymorphic papulosquamous rash with micaceous scales. Paediatr Child Health 2021;26:67-8. [PMID: 33747298 DOI: 10.1093/pch/pxz140] [Reference Citation Analysis]
42 Fu W, Yi S, Qiu L, Sun J, Tu P, Wang Y. BCL11B-Mediated Epigenetic Repression Is a Crucial Target for Histone Deacetylase Inhibitors in Cutaneous T-Cell Lymphoma. J Invest Dermatol 2017;137:1523-32. [PMID: 28288848 DOI: 10.1016/j.jid.2017.02.980] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.2] [Reference Citation Analysis]
43 Finotti A, Fabbri E, Lampronti I, Gasparello J, Borgatti M, Gambari R. MicroRNAs and Long Non-coding RNAs in Genetic Diseases. Mol Diagn Ther 2019;23:155-71. [PMID: 30610665 DOI: 10.1007/s40291-018-0380-6] [Cited by in Crossref: 27] [Cited by in F6Publishing: 22] [Article Influence: 9.0] [Reference Citation Analysis]
44 Yang H, Tao Y, Zhang M, Ma P, Li L, Diao Q. Effects of 9-cis-retinoic acid on the proliferation and apoptosis of cutaneous T-cell lymphoma cells. Anticancer Drugs 2019;30:56-64. [PMID: 30198914 DOI: 10.1097/CAD.0000000000000692] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
45 Şanlı H, Akay BN, Saral S, Okçu Heper A, Topçuoğlu P. Unique Presentation of Leukemic Cutaneous CD3/TCR- Phenotype T-Cell Lymphoma with Complete Remission after Allogeneic Stem Cell Transplantation. Turk J Haematol 2017;34:194-5. [PMID: 28008858 DOI: 10.4274/tjh.2016.0395] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
46 Haller V, Nahidino P, Forster M, Laufer SA. An updated patent review of p38 MAP kinase inhibitors (2014-2019). Expert Opin Ther Pat. 2020;30:453-466. [PMID: 32228113 DOI: 10.1080/13543776.2020.1749263] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 7.5] [Reference Citation Analysis]
47 Marks E, Wang Y, Shi Y, Susa J, Jacobson M, Goldstein DY. Specific TCR gene rearrangements in mycosis fungoides: does advanced clinical stage show a preference? J Clin Pathol 2018;71:1072-7. [PMID: 30171087 DOI: 10.1136/jclinpath-2018-205324] [Reference Citation Analysis]
48 Androutsopoulos VP, Spandidos DA. Antiproliferative effects of TSA, PXD‑101 and MS‑275 in A2780 and MCF7 cells: Acetylated histone H4 and acetylated tubulin as markers for HDACi potency and selectivity. Oncol Rep 2017;38:3412-8. [PMID: 29039546 DOI: 10.3892/or.2017.6015] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
49 Wobser M, Goebeler M. [Cutaneous lymphomas : Clinical presentation - diagnosis - treatment]. Pathologe 2020;41:79-94. [PMID: 31932947 DOI: 10.1007/s00292-019-00743-1] [Reference Citation Analysis]
50 Kottaiswamy A, Kizhakeyil A, Padmanaban AM, Mirza FB, Vijay VR, Lee PS, Verma NK, Kalaiselvan P, Samuel S. The Citrus Flavanone Hesperetin Induces Apoptosis in CTCL Cells via STAT3/Notch1/NFκB-Mediated Signaling Axis. ACAMC 2020;20:1459-68. [DOI: 10.2174/1871521409666200324110031] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
51 Abreu M, Miranda M, Castro M, Fernandes I, Cabral R, Santos AH, Fonseca S, Rodrigues J, Leander M, Lau C, Freitas I, Coimbra S, Santos-Silva A, Lima M. IL-31 and IL-8 in Cutaneous T-Cell Lymphoma: Looking for Their Role in Itch. Adv Hematol 2021;2021:5582581. [PMID: 34335777 DOI: 10.1155/2021/5582581] [Reference Citation Analysis]
52 Dusílková N, Bašová P, Polívka J, Kodet O, Kulvait V, Pešta M, Trněný M, Stopka T. Plasma miR-155, miR-203, and miR-205 are Biomarkers for Monitoring of Primary Cutaneous T-Cell Lymphomas. Int J Mol Sci 2017;18:E2136. [PMID: 29036928 DOI: 10.3390/ijms18102136] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 2.6] [Reference Citation Analysis]
53 Phyo ZH, Shanbhag S, Rozati S. Update on Biology of Cutaneous T-Cell Lymphoma. Front Oncol 2020;10:765. [PMID: 32477957 DOI: 10.3389/fonc.2020.00765] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
54 Rosebush MS, Allen CM, Accurso BT, Baiocchi RA, Cordell KG. Oral Mycosis Fungoides: A Report of Three Cases and Review of the Literature. Head Neck Pathol 2019;13:492-9. [PMID: 29700722 DOI: 10.1007/s12105-018-0923-5] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
55 Khan S, Sawas A. Antibody-Directed Therapies: Toward a Durable and Tolerable Treatment Platform for CTCL. Front Oncol 2019;9:645. [PMID: 31417860 DOI: 10.3389/fonc.2019.00645] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
56 Ortiz-Romero PL, Servitje O, Estrach MT, Izu-Belloso RM, Fernández-de-Misa R, Gallardo F, López-Martínez N, Pérez-Mitru A. Cost of early-stage mycosis fungoides treatments in Spain. Clinicoecon Outcomes Res 2020;12:91-105. [PMID: 32104021 DOI: 10.2147/CEOR.S233376] [Reference Citation Analysis]
57 Stadler R, Stranzenbach R. Molecular pathogenesis of cutaneous lymphomas. Exp Dermatol 2018;27:1078-83. [DOI: 10.1111/exd.13701] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
58 Miyatake J, Inoue H, Serizawa K, Morita Y, Espinoza JL, Tanaka H, Shimada T, Tatsumi Y, Ashida T, Matsumura I. Synchronous Occurrence of Mycosis Fungoides, Diffuse Large B Cell Lymphoma and Acute Myeloid Leukemia. Intern Med 2018;57:1445-53. [PMID: 29321428 DOI: 10.2169/internalmedicine.9668-17] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
59 Dotimas J, Das M, Martin D. Cutaneous T-cell lymphoma in the setting of anti-tumor necrosis factor and immunomodulator therapy: A case report and literature review. SAGE Open Med Case Rep 2020;8:2050313X20937223. [PMID: 32655868 DOI: 10.1177/2050313X20937223] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
60 Hanel W, Briski R, Ross CW, Anderson TF, Kaminski MS, Hristov AC, Wilcox RA. A retrospective comparative outcome analysis following systemic therapy in M ycosis fungoides and S ezary syndrome. Am J Hematol 2016;91:E491-5. [DOI: 10.1002/ajh.24564] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 4.2] [Reference Citation Analysis]
61 Ma H, Abdul-Hay M. T-cell lymphomas, a challenging disease: types, treatments, and future. Int J Clin Oncol 2017;22:18-51. [PMID: 27743148 DOI: 10.1007/s10147-016-1045-2] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
62 Duffy R, Jennings T, Kartan S, Song A, Shi W, Porcu P, Alpdogan O, Sahu J. Special Considerations in the Treatment of Mycosis Fungoides. Am J Clin Dermatol 2019;20:571-8. [PMID: 30993584 DOI: 10.1007/s40257-019-00431-z] [Reference Citation Analysis]
63 Ito A, Sugita K, Ikeda A, Yamamoto O. CD4/CD8 Double-negative Mycosis Fungoides: A Case Report and Literature Review. Yonago Acta Med 2019;62:153-8. [PMID: 30962758 [PMID: 30962758 DOI: 10.33160/yam.2019.03.021] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
64 Wobser M, Goebeler M. [Cutaneous lymphomas : Clinical presentation - diagnosis - treatment]. Hautarzt 2019;70:815-30. [PMID: 31511903 DOI: 10.1007/s00105-019-04469-2] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]